Extended Data Fig. 1. Overview of the study design in the context of the UK biobank Pharma Proteomics Project (UKB-PPP).
a, Study design used for 193 diseases for which only participants from the randomly selected subset were included in the analysis. b, Study design used for 25 less common diseases were incident cases within 10 years of follow-up for the specific disease under study were included in the analysis. Created with BioRender.com.
